Commonwealth Equity Services, Inc - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 50 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.

Quarter-by-quarter ownership
Commonwealth Equity Services, Inc ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$44,000
-6.4%
29,733
-9.9%
0.00%
Q1 2016$47,000
-4.1%
32,983
+11.4%
0.00%
Q4 2015$49,000
-5.8%
29,598
+33.0%
0.00%
-100.0%
Q3 2015$52,000
-8.8%
22,248
+6.0%
0.00%0.0%
Q2 2015$57,000
-30.5%
20,998
-14.6%
0.00%0.0%
Q1 2015$82,000
+17.1%
24,598
+22.1%
0.00%0.0%
Q4 2014$70,000
-30.7%
20,148
+0.4%
0.00%0.0%
Q3 2014$101,000
-57.2%
20,061
+17.6%
0.00%
-66.7%
Q2 2014$236,000
-0.4%
17,061
+10.1%
0.00%0.0%
Q1 2014$237,00015,4960.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders